Genitourinary syndrome of menopause (GSM) responds best to local estrogen — often safe even when systemic HRT isnt.
Vaginal dryness, itching, and painful intercourse are part of GSM (genitourinary syndrome of menopause). Caused by estrogen decline in vaginal tissues. ~50% of postmenopausal women affected, often understreated.
Peri- + postmenopause. Often persists / worsens after VMS resolve. Safe to treat at any age.
All options below are real published treatments. Evidence-level reflects current clinical guidelines (NAMS / ACOG / Endocrine Society). Cost ranges are starting price estimates from $US public sources.
Monthly cost
$30-$120
Side effects
mild local irritation initially, minimal
Topical estrogen restores tissue health locally with minimal systemic absorption. Safe even for most breast cancer survivors (with oncology consult).
Contraindications: Discuss with oncologist if breast cancer history
Providers offering this: midi health, alloy womens health, gennev
Monthly cost
$200-$500 (varies by insurance)
Side effects
hot flashes, muscle spasms, increased VTE risk
Oral non-estrogen option. Useful when topical not preferred OR breast cancer concerns prevent estrogen use.
Monthly cost
$10-$30 OTC
Side effects
minimal
Replens, Hyalo Gyn etc. Help mild symptoms. Use 2-3x weekly. Not and substitute for local estrogen in moderate-severe GSM.
For many breast cancer survivors, low-dose vaginal estrogen is considered safe due to minimal systemic absorption. Coordinate with your oncologist — current consensus from ASCO + NAMS accepts use in most cases.
Last verified 2026-06-01. Treatment guidelines update — confirm with your clinician.